1. |
Miki Y, Swensen J, Shattuck K, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 〔J〕. Science, 1994; 266(5188)∶66.
|
2. |
Sinicrope FA, Rvan SB, Cleary RR, et al. Bcl2 and p53 oncoprotein expression during colorectal tumorigenes 〔J〕. Cancer Res, 1995; 55(2)∶237.
|
3. |
Harris CG. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies 〔J〕. J Natl Cancer Inst, 1996; 88(20)∶1442.
|
4. |
Mitsudomi T, Yatabe Y, Kosshikawa T, et al. Mutations of the p53 tumor suppressor gene as clonal marker for multiple primary lung cancers 〔J〕. J Thorac Cardiovasc Surg, 1997; 114(3)∶354.
|
5. |
Hisada M, Garber JE, Fung CY, et al. Multiple primary cancers in families with LiFraumeni syndrome 〔J〕. J Notl Cancer Inst, 1998; 90(8)∶606.
|
6. |
Alconchel MD, Olivares C, Alvarez R, et al. Squamous cell carcinoma, malignant melanoma and malignant fibrous histiocytoma arising in burn scars 〔J〕. Br J Dermatol, 1997; 137(5)∶793.
|
7. |
Sparks AB, Morin PJ, Vogolstegn B, et al. Mutational analuyusis of the APC/βcatenin/TCF pathway in colorectal cancer 〔J〕. Cancer Res, 1998; (6)∶1130.
|
8. |
Mahmoud NN, Boolbol SK, Bilinski RT, et al. APC gene mutations is assoceated with a dominantnegative effect up intestinal cell migration 〔J〕. Cancer Res, 1997; 57(22)∶5045.
|
9. |
Milner J, Ponder B, Davies L, et al. Transcriptional activation 〔J〕. Nature, 1997; 386(6626)∶772.
|
10. |
Gorden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene 〔J〕. Cell, 1991; 66(3)∶589.
|
11. |
Winchester DP. Breast cancer in young women 〔J〕. Surg Clin North Am, 1996; 76(2)∶279.
|
12. |
Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families 〔J〕. Am J Hum Genet, 1993; 52(4)∶678.
|
13. |
Durocher F, Tonin P, Shattuck ED, et al. Mutation analysis of the BRCA1 gene in 23 families with cancers of the breast ovary and multiple other sites 〔J〕. J Med Genet, 1996; 33(11)∶814.
|
14. |
Radrord DM, Zehnbamer BA. Inherited breast cancer 〔J〕. Surg Clin North Am, 1996; 76(2)∶205.
|
15. |
Couch FJ, Deshano ML, Blackwood MN, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer 〔J〕. N Engl J Med, 1997; 336(20)∶1409.
|
16. |
Easton DF, Narod SA, Fofd D, et al. The genetic epidemiology of BRCA1 〔J〕. Lancet, 1994; 344(8924)∶761.
|
17. |
Wooster R, Mangion J, Nevhausen SL, et al. Localization of a breast cancer susceptibility gene, BRCA2 to chromosome 13q1223 〔J〕. Science, 1994; 265(5181)∶2098.
|
18. |
Donegan WL, Redlich PN. Breast cancer in men 〔J〕. Surg Clin North Am, 1996; 76(2)∶343.
|
19. |
Kamb A, Gruis N, Liu QY, et al. A cell cycle regulator potentially involved in genesis of many tumor types 〔J〕. Science, 1994; 264(5157)∶436.
|
20. |
Nobori T, Miura K, Wu DJ, et al. Deletions of the cyclindependent kinase4 inhibitor gene in multiple human cancers 〔J〕. Nature, 1994; 368(6467)∶753.
|
21. |
Masx J. New tumor suppressor may rival p53 〔J〕. Science, 1994; 264(5157)∶344.
|
22. |
Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas 〔J〕. N Engl J Med, 1998; 338(13)∶879.
|
23. |
Rhel E, Kang L, Bogomolniy F, et al. Mutation analysis of the putative tumour suppressor gene PTEN/MMAC1 in primary breast carcinomas 〔J〕. Cancer Res, 1997; 57(17)∶3657.
|
24. |
Kinzler KW, Vogelstien B. Gatekeepers and caretaker 〔J〕. Nature, 1997; 386(6626)∶761.
|
25. |
Sharan SK, Morimatsu M, Albrecht V, et al. Embryonic lethality and radiation hypersensitivity mediated by rad51 in mice lacking BRCA2 〔J〕. Nature, 1997; 386(6626)∶804.
|